Fakeeh Care Group locks SAR 950m SAB facility in two tranches for expansion

Riyadh - Fakeeh Care Group, known as Dr. Soliman Abdel Kader Fakeeh Hospital Company, just signed a Sharia-compliant credit facility deal with Saudi Awwal Bank (SAB) worth SAR 950 million. The structure matters: the financing is split into two tranches, with SAR 800 million earmarked as long-term funding and SAR 150 million for short-term needs.

The headline number is not just a headline number either. The company explicitly ties this SAR 950 million facility to funding its expansion and growth plans, covering the group and its various subsidiaries, and aiming to enhance service offerings and broaden its footprint in the Saudi healthcare market.

From a board and finance lens, staged financing is a way to match cash to the shape of healthcare expansion. Long-term funding (here, the SAR 800 million tranche) typically aligns with capital-intensive initiatives, like infrastructure developments that take time to build and yield returns later. The smaller short-term tranche (SAR 150 million) is the pressure valve. It is often used for working capital or immediate operational requirements, so the group can keep day-to-day execution stable while larger projects move through their timelines.

This is also a Sharia-compliant credit facility agreement, meaning the terms are designed to align with Islamic banking principles, according to the regulatory disclosure. For institutional investors, lenders, and any healthcare operator operating in Saudi Arabia's financing ecosystem, that framing is not cosmetic. In practice, it can affect how financing is structured, how risk is priced, and which institutions can participate. SAB is the named counterparty, and the agreement was signed under competitive terms and conditions, which signals this was not a casual, off-menu funding arrangement.

Regulatory disclosure adds extra clarity on mechanics. The facility is scheduled to be obtained on 28 June 2026, which places the company’s capital planning slightly ahead of the funding date. That matters because healthcare expansion often forces teams to juggle procurement cycles, staffing timelines, construction windows, and regulatory approvals, all before benefits show up on the balance sheet. Having financing lined up in advance is a way to reduce the risk of pausing projects due to liquidity constraints.

Security for the facility is another detail that will attract attention. The agreement is backed solely by a promissory note, with the disclosure indicating no more restrictive collateral requirements. In plain English, the bank is not taking broader collateral protections within this transaction structure. That can be read in two ways depending on how you view credit risk: either the bank is comfortable with the group’s financial health and creditworthiness, or the company negotiated terms that keep assets from being encumbered. Either way, it is a concrete factor that can influence how flexibly the group can use other resources for future operational and expansion needs.

The disclosure also confirms there are no related parties involved in the transaction. That arm's-length framing is important for governance, because it reduces concerns about conflicts of interest and helps the market interpret the financing as a straightforward lender-borrower decision rather than a connected-party arrangement.

One more operational signal sits in the same disclosure context. The listed company has been awarded the Planetree Gold Certification for Person-Centered Care, reflecting a commitment to a healthcare model that places people, their needs, and their aspirations at the center of all healthcare services and practices. While that certification is not the credit facility itself, it reinforces the company narrative driving the expansion. In healthcare, growth is not only about square meters and equipment. It is also about replicating care models and service standards, which can be more complex and costly than raw capacity expansion.

For executives and board members at peer healthcare operators, this deal is a reminder that the capital conversation is getting more explicit and more structured. SAR 950 million with a two-tranche design, Sharia-compliant terms, promissory-note-only security, and a clear scheduled draw timeline creates a template other players can compare themselves against. The strategic stake is simple: if you plan expansion, you need funding that matches project timelines without strangling liquidity or encumbering collateral more than necessary. Fakeeh Care Group is positioning this facility as the financial runway for its next phase of growth in the Saudi market, and the staged funding suggests it wants to keep momentum while managing operational realities.